TechNovum will run from June to October 2019, providing the UTS institute’s faculty with assistance in validating their biomedical propositions for the market.
UT Health San Antonio, a health education and research institute owned by the University of Texas System (UTS), plans to launch a biomedical accelerator for faculty researchers, San Antonio Business Journal reported yesterday.
The accelerator, named TechNovum, will help the researchers devise business plans and pitch their technologies to potential partners. It will run for four months from June 2019 and culminate with two demo days: one for accredited investors and another for the wider community.
The initial cohort will feature five to eight teams made up of founder inventors, who will learn through an entrepreneurial ideation curriculum that will include weekly classes and guest speakers in areas such as regulatory issues, financing and product development.
Design controls, engineering and biocompatibility are all considered important areas of instruction in which TechNovum can support investigators in achieving market validation of their concepts.
Prospective participants must have cleared a validated technology commercialisation program run by UT Health at San Antonio’s tech transfer office, the Office of Technology Commercialization (OTC), in order to qualify for the initiative.
TechNovum is led by co-directors John Fritz and Sean Thomson, both from OTC, and will receive support from San Antonio Life Sciences Institute, a collaboration between UT Health San Antonio and the local UTS campus, University of Texas at San Antonio.
